Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma

NCT07111104 · clinicaltrials.gov ↗

COMPLETED

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer Metastatic

Interventions

DRUG: Immunotherapy
RADIATION: Radiotherapy

Sponsor

Hopitaux Prives de Metz, Groupe UNEOS